Picture of Bally's logo

BALY Bally's News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsAdventurousMid CapNeutral

U.S. RESEARCH ROUNDUP-Datadog, Macerich Co, Zscaler

Oct 2 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Datadog, Macerich Co and Zscaler, on Monday.
    
    HIGHLIGHTS
                 * Datadog Inc  DDOG.O : Piper Sandler raises to overweight from neutral 
 
                 * Insulet Corp  PODD.O : Jefferies raises to buy from hold 
 
                 * Macerich Co  MAC.N : Piper Sandler raises to neutral from underweight 
 
                 * Splunk Inc  SPLK.O : Piper Sandler cuts to neutral from overweight 
 
                 * Zscaler Inc  ZS.O : Piper Sandler raises to overweight from neutral 
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order. 
    
                 * Abbott Laboratories  ABT.N : Jefferies cuts target price to $112 from $120 
 
                 * Aramark  ARMK.N : RBC cuts target price to $33 from $43 
 
                 * Assurant Inc  AIZ.N : Piper Sandler raises target price to $165 from $150 
 
                 * Ati Physical Therapy Inc  ATIP.N : Jefferies cuts target price to $8 from $14.5 
 
                 * Baker Hughes Co  BKR.O : Jefferies raises target price to $44 from $42 
 
                 * Bally'S Corp  BALY.N : Jefferies cuts target price to $15 from $17 
 
                 * Boyd Gaming Corp  BYD.N : Jefferies cuts target price to $69 from $76 
 
                 * Brighthouse Financial Inc  BHF.O : Piper Sandler cuts target price to $50 from $55 
 
                 * Brp Group Inc  BRP.O : JP Morgan cuts target price to $27 from $28 
 
                 * Carnival Corp  CCL.N : JP Morgan cuts target price to $19 from $21 
 
                 * CBRE Group Inc  CBRE.N : JP Morgan cuts target price to $83 from $89 
 
                 * Chesapeake Utilities Corp  CPK.N : RBC cuts target price to $117 from $124 
 
                 * Chewy, Inc.  CHWY.N : Barclays cuts target price to $20 from $28 
 
                 * Chico'S Fas Inc  CHS.N : B. Riley cuts to neutral rating; raises target price to $7.6 
 
                 * Churchill Downs Inc  CHDN.O : Jefferies cuts target price to $147 from $157 
 
                 * Conocophillips  COP.N : Jefferies raises target price to $143 from $141 
 
                 * Datadog Inc  DDOG.O : Piper Sandler raises target price to $115 from $88 
 
                 * Datadog Inc  DDOG.O : Piper Sandler raises to overweight from neutral 
 
                 * Eli Lilly  LLY.N : TD Cowen raises target price to $635 from $500 
 
                 * Golden Entertainment Inc  GDEN.O : Jefferies cuts target price to $39 from $41 
 
                 * Goosehead Insurance Inc  GSHD.O : JP Morgan raises target price to $60 from $58 
 
                 * Halliburton Co  HAL.N : Jefferies raises target price to $51 from $49 
 
                 * Insulet Corp  PODD.O : Jefferies cuts target price to $240 from $260 
 
                 * Insulet Corp  PODD.O : Jefferies raises to buy from hold 
 
                 * Intellia Therapeutics Inc  NTLA.O : JP Morgan cuts target price to $74 from $79 
 
                 * Jones Lang LaSalle Inc  JLL.N : JP Morgan cuts target price to $187 from $192 
 
                 * Kellanova  K.N : Jefferies cuts target price to $62 from $72 
 
                 * Kellanova  K.N : Piper Sandler cuts target price to $57 from $72 
 
                 * Kinsale Capital Group Inc  KNSL.N : JP Morgan raises target price to $370 from $350 
 
                 * Las Vegas Sands Corp  LVS.N : Jefferies cuts target price to $52 from $65 
 
                 * Lincoln National Corp  LNC.N : Piper Sandler cuts target price to $27 from $29 
 
                 * Macerich Co  MAC.N : Piper Sandler raises target price to $12 from $11 
 
                 * Macerich Co  MAC.N : Piper Sandler raises to neutral from underweight 
 
                 * Monarch Casino & Resort Inc  MCRI.O : Jefferies cuts target price to $72 from $78 
 
                 * Nike Inc  NKE.N : RBC cuts target price to $113 from $134 
 
                 * Omnicom Group Inc.  OMC.N : Barclays cuts target price to $95 from $105 
 
                 * Penn Entertainment Inc  PENN.O : Jefferies cuts target price to $25 from $30 
 
                 * Principal Financial Group Inc  PFG.O : Piper Sandler cuts target price to $80 from $82 
 
                 * Progressive Corp  PGR.N : JP Morgan raises target price to $149 from $146 
 
                 * Red Rock Resorts Inc  RRR.O : Jefferies raises target price to $55 from $54 
 
                 * Republic Services Inc  RSG.N : RBC raises target price to $166 from $163 
 
                 * Sherwin-Williams Co  SHW.N : Berenberg raises target price to $249 from $224 
 
                 * Slb  SLB.N : Jefferies raises target price to $75 from $70 
 
                 * Splunk Inc  SPLK.O : Piper Sandler cuts to neutral from overweight 
 
                 * Structure Therapeutics Inc  GPCR.O : Jefferies raises target price to $79 from $50 
 
                 * Structure Therapeutics Inc  GPCR.O : Leerink Partners raises target price to $97 from $46 
 
                 * Tandem Diabetes Care Inc  TNDM.O : Jefferies cuts target price to $45 from $47 
 
                 * Utz Brands Inc  UTZ.N : Piper Sandler cuts target price to $17 from $22 
 
                 * Wk Kellogg Co  KLG.N : Jefferies initiates coverage with hold rating; target price $15 
 
                 * Workday Inc  WDAY.O : Evercore ISI cuts target price to $265 from $275 
 
                 * Wynn Resorts Ltd  WYNN.O : Jefferies cuts target price to $104 from $118 
 
                 * Xencor Inc  XNCR.O : JP Morgan cuts target price to $37 from $45 
 
                 * Zscaler Inc  ZS.O : Piper Sandler raises target price to $190 from $160 
 
                 * Zscaler Inc  ZS.O : Piper Sandler raises to overweight from neutral 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Bally's

See all news